Cyteir Leadership 2019-02-07T12:55:55+00:00

Cyteir Leadership


Markus Renschler, MD
Markus Renschler, MDPresident and Chief Executive Officer
Kevin Mills, PhD
Kevin Mills, PhDFounder and Chief Scientific Officer
Jean-Marc Lapierre, PhD
Jean-Marc Lapierre, PhDVice President of Chemistry
Tom O'Shea, PhD
Tom O'Shea, PhDVice President of Preclinical Development

“It is with patients in the forefront of our minds that we work diligently to develop novel gain of function synthetic lethal therapies”

Melinda Anne Lynch Day, PhD – Principal Scientist, Cyteir Therapeutics, Inc.